comparemela.com
Home
Live Updates
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer -April 01, 2024 at 08:06 am EDT : comparemela.com
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer -April 01, 2024 at 08:06 am EDT
First of its kind study in muscle-invasive urothelial cancer, with both escalation and de-escalation arms
Approximately 1,000 patients will be enrolled at more than 300 sites
...
Related Keywords
California ,
United States ,
San Carlos ,
Texas ,
Canada ,
America ,
Matthew Galsky ,
Androl Urol ,
Clinical Laboratory Improvement Amendments ,
National Cancer Institute ,
Alliance For Clinical Trials In Oncology ,
Nasdaq ,
Community Research Oncology Program ,
National Clinical Trials Network ,
Kantar Health Cerner Enviza ,
National Institutes Of Health ,
Natera Inc ,
Tisch Cancer Institute ,
Clinical Trials ,
National Institutes ,
Bladder Cancer ,
Tisch Cancer ,
Minetta Liu ,
Research Oncology Program ,
Looking Statements ,
Kantar Health ,
Cerner Enviza ,
Transl Androl ,
Markets ,
comparemela.com © 2020. All Rights Reserved.